Clinical Trials Browser

Recruiting × FED × enzalutamide × Clear all

NCT03753243 2022-04-20

Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer

Phase 2 Recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms